Jaime Bartushak

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cranford, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Alexander M. Donaldson, by Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jaime Bartushak

Form 4 holding Chief Financial Officer

CITIUS ONCOLOGY, INC.

Security class
Stock Option (Right to Buy)
Shares / value
1,400,000
Estimated value
$2,926,000
Report date
19 Sep 2025
Price
$2.09
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,400,000
Form 4 holding Chief Financial Officer

Citius Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
60,353
Estimated value
$45,265
Report date
07 Nov 2024
Price
$0.7500
Ownership
Direct
Form 4 holding Chief Financial Officer

Citius Pharmaceuticals, Inc.

Security class
Stock Option (Right to Purchase Common Stock)
Shares / value
350,000
Estimated value
Report date
07 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jaime Bartushak

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .